Hemostais, adipokines, rennin-angiotensin system gene polymorphisms and target organ damage in young patients with hypertension and abdominal obesity


DOI: https://dx.doi.org/10.18565/therapy.2019.1.82-88

Chulkov Vl.S., Vereina N.K., Chulkov V.S., Tarasova O.A., Sinitsyn S.P.

Federal State budgetary educational institution «South Ural State medical University» of the Ministry of Healthcare of Russia, Chelyabinsk
The purpose of the study is to evaluate the relationship of hemostasis rates, adipokines levels, renin-angiotensin system genes polymorphisms and target organ damage in young patients with hypertension and abdominal obesity. Material and methods. The study included 251 persons. A comprehensive assessment of the relationship of the hemostasis system, adipokines, polymorphisms of the genes of the renin-angiotensin system with the state of the target organ damage in young patients with hypertension and abdominal obesity has been carried out. Results. In patients aged 18-44 years with hypertension and abdominal obesity a higher levels of leptin, fibrinogen, plasminogen activator inhibitor type 1 and an inhibitor of the tissue factor pathway were found. A higher frequencies of M-allele of T174M and T-allele of M235T polymorphisms of angiotensinogen gene and C-allele of A1166C polymorphism of angiotensin II receptor gene were detected in association with target organ damage in young patients with hypertension and abdominal obesity. Conclusion. The above features of hemostasis, adipokines, and the prevalence of allelic variants of renin-angiotensin system genes make it possible to expand the understanding of pathogenetic mechanisms of the development of the metabolic syndrome at a young age.

Literature



  1. Benjamin E., Blaha M., Chiuve S., Cushman M. et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017; 135(10): e146–e603. DOI: 10.1161/CIR.0000000000000485.

  2. James P., Oparil S., Carter B., Cushman W. et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311(5): 507–20. DOI: 10.1001/jama.2013.284427.

  3. Шупина М.И., Нечаева Г.И., Повстяная А.Н., Семенкин А.А. Ранняя диагностика артериальной гипертензии у лиц молодого возраста. Лечащий врач. 2015; 2: 22–29.

  4. WHO. Obesity and overweight, 2014. http://www.who.int/mediacentre/factsheets/fs311/en/.

  5. Шляхто Е.В., Недогода С.В., Конради А.О., Баранова Е.И. и др. Концепция новых национальных клинических рекомендаций по ожирению. Российский кардиологический журнал. 2016; 4; 7–13.

  6. Чазова И.Е., Недогода С.В., Жернакова Ю.В., Сусеков А.В. и др. Рекомендации по ведению больных с артериальной гипертонией с метаболическими нарушениями. Кардиологический вестник. 2014; 1: 3–57.

  7. Бойцов С.А., Баланова Ю.А., Шальнова С.А., Деев А.Д. и др. Артериальная гипертония среди лиц 25–64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования ЭССЕ. Кардиоваскулярная терапия и профилактика. 2014; 13(4): 4–14. DOI: 10.15829/1728-8800-2014-4-4-14.

  8. Чулков В.С., Гаврилова Е.С., Чулков В.С., Минина Е.Е. Репродуктивное здоровье и кардиометаболический риск. Сибирское медицинское обозрение. 2018; 4: 13–21. DOI: 10.20333/2500136-2018-4-13-21.

  9. Benetos A., Thomas F., Pannier B., Bean K. et al. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome. Am. J. Cardiol. 2008; 102(2): 188–191. DOI: 10.1016/j.amjcard.2008.03.037.

  10. Сумеркина В.А., Чулков В.С., Чулков В.С., Ожигина Е.В. Состояние системы гемостаза и цитокиновый профиль у пациентов с метаболическим синдромом. Казанский медицинский журнал. 2015; 96(5): 728–34. DOI: 10.17750/KMJ2015-728.

  11. Marwick T.H., Gillebert T.C., Aurigemma G., Chirinos J. et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). European Heart Journal – Cardiovascular Imaging 2015; 16: 577–605. DOI: 10.1093/ehjci/jev076.

  12. Stein J.S., Korcarz C.E., Post W.S. Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: Summary and Discussion of the American Society of Echocardiography Consensus Statement. Preventive Cardiology. Winter. 2009: 34–38.


About the Autors


Vladislav S. Chulkov, assistant of the faculty therapy Department of South Ural State medical University. Address: 454092, Chelyabinsk, 64 Vorovsky str. E-mail: vlad.chulkov.1989@mail.ru
Natalya K. Vereina, MD, PhD, professor of the faculty therapy Department of South Ural State medical University. Address: 454092, Chelyabinsk, 64 Vorovsky str. E-mail: vereinanata@yandex.ru
Vasilii S. Chulkov, MD, PhD, associated professor of the faculty therapy Department of South Ural State medical University. Address: 454092, Chelyabinsk, 64 Vorovsky str. E-mail: vschulkov@rambler.ru
Olesya Al. Tarasova, senior laboratory assistant of the faculty therapy Department of South Ural State medical University. Address: 454092, Chelyabinsk, 64 Vorovsky str. E-mail: Tarasova.o.a@bk.ru
Sergei P. Sinitsyn, MD, PhD, professor, head of the faculty therapy Department of South Ural State medical University. Address: 454092, Chelyabinsk, 64 Vorovsky str. E-mail: sinitsinsp@lenta.ru


Similar Articles


Бионика Медиа